Hepatitis Drugs

The government of India has signed 25 Memorandum of Understandings (MoUs) for country to country cooperation in the field of medicine Nepal, Bangladesh, Hungary, Trinidad & Tobago, Malaysia, Mauritius, Mongolia, Turkmenistan, Myanmar, World Health Organization,   Germany, Iran, Sao Tome & Príncipe, Equatorial Guinea, Cuba, Colombia, Japan, Bolivia, Gambia, Republic of Guinea, China, St Vincent and The Grenadines, Suriname, Brazil and Zimbabwe. 33 MoUs for undertaking collaborative research and development of Traditional Medicine has been signed with foreign Institutes/Universities/Organizations from USA, Germany, UK, Canada, Malaysia, Brazil, Australia, Austria, Tajikistan, Saudi Arabia, Ecuador, Japan, Indonesia, and Reunion Island, Korea, Hungary. 14 MoUs have been signed for setting up of Ayush Academic Chairs in foreign Institutes/Universities from Hungary, Latvia, Mauritius, Bangladesh, Russia, West-Indies, Thailand, Indonesia, Slovenia, Armenia, Argentina, Malaysia, South Africa, Australia. The constituent laboratory of Council of Scientific & Industrial Research namely Institute of Himalayan Bio-resource Technology (CSIR-IHBT), Palampur has signed an MoU with National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan, to collaborate in the areas of mutual interest which included medicinal plants, bioactive molecules, herbal formulations etc.  CSIR and Bill & Melinda Gates Foundation have signed an MoU to identify the opportunities for scientific and technological research between researchers located within and outside of India, including collaborations with foundation-funded entities in the areas including but not limited to traditional medicine (AYUSH)-guided by specific applications to disease/ health priorities. Under the Central Sector Scheme for Promotion of International Co-operation in AYUSH (IC Scheme), the Ministry of Ayush supports AYUSH drug manufacturers, entrepreneurs, AYUSH institutions and Hospitals etc. for the international propagation of AYUSH by participating in international exhibitions, trade fairs, roadshows etc. to display their products and services. Ayush Oushadhi Gunvatta evam Uttpadan Samvardhan Yojana (AOGUSY) of Ministry of Ayush has been initiated for augmenting the quality of Ayush drugs during the 15th Finance Cycle (2021-22 to 2025-26) by merging the existing Central Sector Schemes of Pharmacovigilance initiative, Central Drug Controller of Ayush and Quality Control of ASU&H drugs {Component of National Ayush Mission (NAM)} and inclusion of certain new elements to facilitate standardization, effective enforcement of rules/regulations, technology up-gradation for manufacturing and analytical testing, certification/accreditation, training and capacity building activities intended towards quality assurance of Ayush drugs. The Prime Minister Employment Generation Programme (PMEGP) of Ministry of Micro Small and Medium Enterprises (MSME), Government of India is available to the Industry for availing benefits under Manufacturing and Service Sector including Ayush. Indian medicine Pharmaceutical Corporation Limited (IMPCL) which is a Mini Ratna Central Public Sector Enterprise (CPSE) under the Ministry of Ayush (Government of India) is manufacturing of Ayurveda & Unani Medicines in India. Ayurveda, Unani and Siddha is recognized under the NCISM act and are being practiced all over India. This information was given by Minister of Ayush Shri Sarbananda Sonowal in a written reply in Lok Sabha today. Read More► Promotion of Local Traditional Medicine

Recently a research report on AYUSH Sector has been published by Forum on Indian Traditional Medicine (FITM) under Research and Information system for developing country (RIS), which is an autonomous policy research institute at New Delhi. As per the report, the current turnover of Indian AYUSH industry is US$ 18.1 billion and the market size of Indian AYUSH industry as a whole, has grown by 17 per cent during 2014-2020. The total AYUSH & herbal medicines export of India has increased from US$ 1.09 billion in 2014 to US$ 1.54 billion in 2020, registering a robust growth rate of 5.9 per cent annually. The Ministry of Ayush, Government of India has developed a Central Sector Scheme for Promotion of International Co-operation in AYUSH (IC Scheme) with the mandate to promote and strengthen awareness and interest about AYUSH Systems of Medicine at international level to facilitate International promotion, development and recognition of AYUSH system of medicine to foster interaction of stakeholders and market development of AYUSH at international level to give boost to AYUSH  products/services/education/research/ training globally to promote academics and research through establishment of AYUSH Academic Chairs in foreign countries setting up of AYUSH Information Cell abroad to disseminate authentic information about Ayush system in the foreign communities etc. Under the AYUSH Fellowship program of the IC scheme, 104 scholarships are offered every year to the eligible foreign nationals from 101 countries for pursuing AYUSH courses in premier Institutes in India. Ministry has signed 14 MoUs for setting up AYUSH Academic Chairs with foreign Universities/institutes under which AYUSH experts are deputed to undertake teaching/training/research activities. Various multilateral forums like G 20, BIMSTEC, BRICS, IBSA, SCO etc. are being effectively utilized to get global recognition to Ayurveda and other AYUSH systems. Ministry of Ayush has signed an agreement with London School of Hygiene & Tropical Medicine (LSH&TM), UK for conducting the study on “Ashwagandha for promoting recovery from Covid-19 in the UK”. Ministry of Ayushhas also signed an agreement with Frankfurter Innovationszentrum Biotechnologie GmbH (FIZ), Frankfurt Germany for conducting Collaborative Research study on Guduchyadi tablets in combating COVID-19 infection- In-vitro & in-vivo study. This information was given by Minister of Ayush Shri Sarbananda Sonowal in a written reply in Lok Sabha today. Read More► Action Plan to Standardise Product of Ayush and Its Manufacturing Process

To make regulators and manufacturers conversant with practical aspects of enforcement and manufacturing issues of Ayurveda, Siddha, Unani and Homeopathy (ASU&H) drugs, the Ministry of Ayush organised a two-day training programme on Thursday. This is the first of the five training sessions to be organised by the drug policy section of the ministry, over a period three months. Held at Regional Ayurveda Research Institute, Mandi, Himachal Pradesh for the northern zone, the training session was attended by 40 delegates from Himachal Pradesh, Uttarakhand, Punjab, Chandigarh, Ladakh, Jammu and Kashmir and Haryana. The programme covers existing regulatory provisions, GMP, WHO-GMP, DTL, testing of ASU&H drugs, schemes for Industry and State drug control framework. It’s a two way interactive programme where the centre, state and stakeholders meet for hand holding and encouragement of the work being done with the target of quality AYUSH medicines. According to ministry officials, the purpose of the training session is to bring the clarity about the regulations among the ASU&H drug regulators and ASU&H drug industry personnel at a common platform. Each State/UT amongst the AYUSH Drug Regulators, Industry personnel and other stakeholders nominate their representatives to attend the training session. The training sessions are being organised by the drug policy section of the Ministry in collaboration with Central Council for Research in Ayurvedic Sciences and various National Institutes. Read More► Ministry Sets Up Expert Group to Examine Advisory Against Using Ashwagandha Leaves in ASU Drugs

आयुष मंत्रालयाने यासाठी तज्ञ गटाची स्थापना करून एएसयू (आयुर्वेद, सिद्ध आणि युनानी) औषधांमध्ये अश्वगंधा (विथानिया सोम्निफेरल) पानांच्या वापराशी संबंधित प्रकरणाची पुन्हा तपासणी करण्याचा निर्णय घेतला आहे. यापूर्वी, मंत्रालयाने ASU औषधांमध्ये अश्वगंधाच्या पानांच्या वापराविरोधात मार्गदर्शक तत्वे जारी केली होती. आयुष मंत्रालयाने अश्वगंधा पानांचा वापर प्रतिबंधित केल्याच्या पार्श्वभूमीवर एएसयू औषध निर्मण उद्योगांच्या भागीदारांकडून निवेदने प्राप्त झाली होती. तसेच, आयुष मंत्रालयाने हितधारकांना एएसयू उत्पादनांमध्ये अश्वगंधाच्या पानांच्या वापराबाबत समस्यांवर चर्चा करण्यासाठी आमंत्रित केले होते. या चर्चेच्या आधारे, मंत्रालयाने तज्ज्ञ गट स्थापन करून अश्वगंधा (विथानिया सोम्निफेरा) पाने वापरण्यापासून परावृत्त करण्यासाठी औषध उत्पादकांना जारी केलेल्या मार्गदर्शक तत्वे पुन्हा तपासून पाहण्याचा निर्णय घेतला आहे. वैज्ञानिक पुराव्याच्या आधारे एएसयू उत्पादनांमध्ये अश्वगंधाची पाने/अश्वगंधाच्या पंचांगाच्या वापराबाबत तज्ञ गट सरकारला योग्य शिफारसी करेल. पुढे वाचा► आयुष-64 ची मागणी आता सहज पूर्ण होणार; सीसीआरएएस ने 46 कंपन्यांना तंत्रज्ञान हस्तांतरित केले